Learning Objectives:

  1. Identify the demographics, prevalence, and outcomes associated with heart failure with preserved ejection fraction.
  2. Review the current pathophysiological mechanism underlying heart failure with preserved ejection fraction and the relationship to clinical trial outcomes.
  3. Identify the role of renal insufficiency in heart failure with preserved ejection fraction and describe the current therapeutic interventions.
Session date: 
05/26/2023 - 12:00pm to 1:00pm CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
James Fang, MD